Adaptive Biotechnologies Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $604.0M | $139.1M |
| FY2022 | $125.4M | $464.2M | $90.0M |
| FY2023 | $130.7M | $308.4M | $65.1M |
| FY2024 | $132.4M | $202.7M | $47.9M |
| FY2025 | $126.6M | $218.8M | $70.5M |